Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
UK IGA NEPHROPATHY Competitive Intelligence
UK IGA NEPHROPATHY Competitive Intelligence
Budesonide and sparsentan must clear NICE's standard £20,000-30,000/QALY bar, since IgA Nephropathy is too common for the ultra-rare HST track.
An estimated...
